Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Commercial
Lawsuits/Bankruptcy
Lawsuits/Bankruptcy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lawsuits/Bankruptcy
BTL Files Lawsuit against Allergan for False Advertising and Unfair Competition
Biospace News
-
February 20, 2020
Lawsuits/Bankruptcy
BTL Files Lawsuit against Allergan for False Advertising and Unfair Competition
Lawsuits/Bankruptcy
Sanofi indicted in France over epilepsy drug Depakine
Lawsuits/Bankruptcy
Insys Founder Sentenced to 66 Months for Scheme to Boost Opioid Sales
Lawsuits/Bankruptcy
EU legal official says GlaxoSmithKline’s ‘pay-for-delay’ deals breach competition law
Lawsuits/Bankruptcy
Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS (linaclotide) Patent...
Firstwordpharma News
-
January 22, 2020
0
Lawsuits/Bankruptcy
U.S. District Court Rules in Favor of Lilly in Alimta Vitamin...
Firstwordpharma News
-
December 30, 2019
0
Lawsuits/Bankruptcy
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
Biospace News
-
December 18, 2019
0
Lawsuits/Bankruptcy
ADMS LOSS NOTICE ALERT: TOP RANKED Rosen Law Firm Announces Filing...
Biospace News
-
December 14, 2019
0
Lawsuits/Bankruptcy
SHAREHOLDER ALERT: WeissLaw LLP Investigates Synthorx, Inc.
Biospace News
-
December 12, 2019
0
1
2
3
...
12
Page 1 of 12
- Advertisement -
MOST POPULAR
Amgen Closes Out Neuroscience Programs as it Focuses on Long-Term Growth...
October 30, 2019
Eisai Commences Joint Research And Development Of Cancer Gene Panel Test...
January 29, 2020
FDA panel votes down Correvio’s atrial fibrillation drug Brinavess citing safety...
December 10, 2019
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
January 17, 2020
Load more
HOT NEWS
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from...
Neurology
BioArctic Announces That Eisai Will Initiate Phase 3 Confirmatory Study With...
Approval
Alimera Sciences Announces Approval for ILUVIEN in Kuwait
Deals
Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics...
